$BNGO Fascinating post from cdminor1: “. I kinda think BNGO doesn't care about the SP. All they care about is the science. BNGO, ILSLF, and everyone else who has invested knows that Saphyr is going to replace most of the current cytogenetic testing equipment. Even if BNGO dilutes the shares 10x its current shares, in time this will be huge and everyone will make money.” Note that at a 10x dilution [to about 500 million shares] the company would need a $750 million valuation for shareholders to get $1.50 p/s.